Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawal

López-Castillo, DanielMarch-Rodríguez, AlvaroRodriguez-Vida, AlejoPujol Vallverdú, Ramon MariaSegura Tigell, Sonia2021-05-032021-05-032020Lopez-Castillo D, March-Rodriguez A, Rodriguez-Vida A, Pujol RM, Segura S. Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawal. Acta Derm Venereol. 2020 Mar 12; 100(6): adv00079. DOI: 10.2340/00015555-34380001-5555http://hdl.handle.net/10230/47275application/pdfengThis is an open access article under the CC BY-NC license. http://creativecommons.org/licenses/by-nc/4.0/ www.medicaljournals.se/acta Journal Compilation © 2020 Acta Dermato-Venereologica.Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawalinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.2340/00015555-3438Calcinosis cutisDigital ulcersHyperphosphatemiaInhibitorSkin adverse reactionFibroblast growth factor receptorinfo:eu-repo/semantics/openAccess